KORU Medical Systems
Emily DiMambro is a seasoned professional in regulatory affairs with extensive experience in the medical device industry, currently serving as Principal Regulatory Affairs Specialist at KORU Medical Systems since May 2022. Previous roles include Senior Regulatory Specialist and Staff Regulatory Affairs Specialist at Stryker, where contributions involved managing 510(k) submissions, maintaining compliance with EU MDR, and overseeing a major transition to a new PLM system. Emily began a regulatory career at the FDA and has also engaged in research on biocomposite materials and consulted on communication techniques. Emily holds a Bachelor of Science in Biomedical Engineering from Rensselaer Polytechnic Institute.
This person is not in any offices
KORU Medical Systems
The home infusion industry turns to KORU Medical Systems to help patients and medical professionals improve infusion therapy experiences and we have a passion and vision for doing just that! We focus on home and specialty infusion solutions, emphasizing responsive problem-solving for our customers with careful consideration to the patient experience. The company was incorporated in March 1980 and is now publicly traded on the NASDAQ Capital Market (NASDAQ: KRMD). We are located in Mahwah, NJ (USA), approximately 30 miles northwest of New York City. Our primary products include the FREEDOM60® and FreedomEdge® Syringe Infusion Systems, Precision Flow Rate Tubing™, and HIgH-Flo Subcutaneous Safety Needle Sets.